Literature DB >> 6601554

Impaired production of interleukins in patients with cell-mediated immunodeficiencies.

R Paganelli, F Aiuti, P C Beverley, R J Levinsky.   

Abstract

The poor mitogen response to phytohaemagglutinin (PHA) of lymphocytes from three patients with cell-mediated immunodeficiencies was restored to normal when supernatants containing interleukin 2 (IL-2) were added. One of three children with severe combined immunodeficiency also showed a partial response. There was no improvement in the normal mitogenic response of the lymphocytes from patients with either the X linked or common variable forms of hypogammaglobulinaemia. All three patients with cell-mediated immunodeficiencies showed gross imbalance in the ratio of helper/inducer (OKT4+) to suppressor/cytotoxic (OKT8+) T cells. The PHA stimulated culture supernatant from one of these patients failed to induce proliferation of a cytolytic continuous T cell line. Our data suggests that the underlying defect in these patients may be a failure in production of interleukins but not in the acquisition of IL-2 receptors.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6601554      PMCID: PMC1536882     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  15 in total

1.  T cell stimulating growth factors.

Authors: 
Journal:  Immunol Rev       Date:  1980       Impact factor: 12.988

2.  Role of interleukins 1 and 2 on human thymocyte mitogen activation.

Authors:  M Piantelli; L Lauriola; N Maggiano; F O Ranelletti; P Musiani
Journal:  Cell Immunol       Date:  1981-11-01       Impact factor: 4.868

3.  Distinctive functional characteristics of human "T" lymphocytes defined by E rosetting or a monoclonal anti-T cell antibody.

Authors:  P C Beverley; R E Callard
Journal:  Eur J Immunol       Date:  1981-04       Impact factor: 5.532

4.  Spontaneous suppressor cells for mitogen responsiveness of cord blood lymphocytes.

Authors:  R Paganelli
Journal:  Clin Immunol Immunopathol       Date:  1981-12

Review 5.  Cellular origins and targets of costimulator (IL2).

Authors:  V Paetkau; J Shaw; G Mills; B Caplan
Journal:  Immunol Rev       Date:  1980       Impact factor: 12.988

Review 6.  The differentiation and function of human T lymphocytes.

Authors:  E L Reinherz; S F Schlossman
Journal:  Cell       Date:  1980-04       Impact factor: 41.582

7.  Absolute macrophage dependency of T lymphocyte activation by mitogens.

Authors:  D L Rosenstreich; J J Farrar; S Dougherty
Journal:  J Immunol       Date:  1976-01       Impact factor: 5.422

8.  Treatment of cell-mediated immunodeficiency with calf thymic hormone (T.P.I.).

Authors:  E G Davies; R J Levinsky
Journal:  Pediatr Res       Date:  1982-07       Impact factor: 3.756

Review 9.  Human T-lymphocyte growth factor: regulation of growth and function of T lymphocytes.

Authors:  F W Ruscetti; R C Gallo
Journal:  Blood       Date:  1981-03       Impact factor: 22.113

10.  T cell requirements for generation of helper factor(s) in man: analysis of the subsets involved.

Authors:  E L Reinherz; P C Kung; J M Breard; G Goldstein; S F Schlossman
Journal:  J Immunol       Date:  1980-04       Impact factor: 5.422

View more
  14 in total

1.  Recombinant interleukin 2 therapy in severe combined immunodeficiency disease.

Authors:  R Pahwa; T Chatila; S Pahwa; C Paradise; N K Day; R Geha; S A Schwartz; H Slade; N Oyaizu; R A Good
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

Review 2.  Lymphocyte proliferation, lymphokine production, and lymphocyte receptors in ageing and various clinical conditions.

Authors:  A L de Weck; F Kristensen; F Joncourt; F Bettens; C Walker; Y Wang
Journal:  Springer Semin Immunopathol       Date:  1984

3.  Cell-mediated immunodeficiency in Down's syndrome: normal IL-2 production but inverted ratio of T cell subsets.

Authors:  R Karttunen; T Nurmi; J Ilonen; H M Surcel
Journal:  Clin Exp Immunol       Date:  1984-02       Impact factor: 4.330

4.  Interleukin-2 reverses deficient cell-mediated immune responses in rheumatoid arthritis.

Authors:  P Emery; G S Panayi; A M Nouri
Journal:  Clin Exp Immunol       Date:  1984-07       Impact factor: 4.330

5.  Evidence that defective gamma interferon production in patients with primary immunodeficiencies is due to intrinsic incompetence of lymphocytes.

Authors:  R Paganelli; M R Capobianchi; B Ensoli; G P D'Offizi; J Facchini; F Dianzani; F Aiuti
Journal:  Clin Exp Immunol       Date:  1988-04       Impact factor: 4.330

6.  Interferon production in primary immunodeficiencies.

Authors:  P M Matricardi; M R Capobianchi; R Paganelli; J Facchini; M C Sirianni; R Seminara; F Dianzani; F Aiuti
Journal:  J Clin Immunol       Date:  1984-09       Impact factor: 8.317

7.  Interleukin-2 production and response to exogenous interleukin-2 in a patient with the acquired immune deficiency syndrome (AIDS).

Authors:  G J Hauser; T Bino; H Rosenberg; V Zakuth; E Geller; Z Spirer
Journal:  Clin Exp Immunol       Date:  1984-04       Impact factor: 4.330

8.  Impaired production of interleukin-2 after surgery.

Authors:  T Akiyoshi; F Koba; S Arinaga; S Miyazaki; T Wada; H Tsuji
Journal:  Clin Exp Immunol       Date:  1985-01       Impact factor: 4.330

9.  In vitro effect of interleukin 2 on depression of cell-mediated immune response after surgery.

Authors:  T Akiyoshi; F Koba; S Arinaga; T Wada; H Tsuji
Journal:  Jpn J Surg       Date:  1985-09

10.  Abnormal lymphocyte response to exogenous interleukin-2 in homosexuals with acquired immune deficiency syndrome (AIDS) and AIDS related complex (ARC).

Authors:  J L Murray; E M Hersh; J M Reuben; C G Munn; P W Mansell
Journal:  Clin Exp Immunol       Date:  1985-04       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.